(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 179.5% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.59%.
Uniqure Nv's revenue in 2026 is $15,751,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $2,380,039,860, with the lowest QURE revenue forecast at $640,981,212, and the highest QURE revenue forecast at $9,098,320,298. On average, 11 Wall Street analysts forecast QURE's revenue for 2027 to be $10,881,107,693, with the lowest QURE revenue forecast at $1,599,400,739, and the highest QURE revenue forecast at $23,502,021,533.
In 2028, QURE is forecast to generate $22,015,742,454 in revenue, with the lowest revenue forecast at $8,768,174,484 and the highest revenue forecast at $38,744,791,469.